By Kevin E. Noonan — Despite the challenges of addressing a previously unknown virus, development of an effective vaccine, soon, is a distinct possibility (see “Multiple Candidate Coronavirus Vaccines Being Developed According to WHO”). But as set forth in an article in Nature on Monday (“The unequal scramble for coronavirus vaccines — by the numbers”) by Ewen Callaway, there is a legitimate concern that such vaccines may not be equitably accessible based on medical need. The issue is a practical one: how to produce enough doses in a short enough time to be effective in stemming the pandemic and delivering…
